- Home
- ABLV vs JSPR Comparison
ABLV vs JSPR Comparison
Compare ABLV & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- JSPR
- Stock Information
- Founded
- ABLV 2015
- JSPR 2018
- Country
- ABLV China
- JSPR United States
- Employees
- ABLV N/A
- JSPR N/A
- Industry
- ABLV
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ABLV
- JSPR Health Care
- Exchange
- ABLV Nasdaq
- JSPR Nasdaq
- Market Cap
- ABLV 51.4M
- JSPR 47.6M
- IPO Year
- ABLV N/A
- JSPR N/A
- Fundamental
- Price
- ABLV $1.04
- JSPR $2.59
- Analyst Decision
- ABLV
- JSPR Buy
- Analyst Count
- ABLV 0
- JSPR 12
- Target Price
- ABLV N/A
- JSPR $30.78
- AVG Volume (30 Days)
- ABLV 8.1K
- JSPR 168.7K
- Earning Date
- ABLV 04-23-2025
- JSPR 11-06-2025
- Dividend Yield
- ABLV N/A
- JSPR N/A
- EPS Growth
- ABLV N/A
- JSPR N/A
- EPS
- ABLV N/A
- JSPR N/A
- Revenue
- ABLV $128,932,647.00
- JSPR N/A
- Revenue This Year
- ABLV N/A
- JSPR N/A
- Revenue Next Year
- ABLV N/A
- JSPR N/A
- P/E Ratio
- ABLV N/A
- JSPR N/A
- Revenue Growth
- ABLV N/A
- JSPR N/A
- 52 Week Low
- ABLV $0.55
- JSPR $2.27
- 52 Week High
- ABLV $1.74
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- ABLV 61.46
- JSPR 33.63
- Support Level
- ABLV $0.84
- JSPR $2.58
- Resistance Level
- ABLV $0.90
- JSPR $2.87
- Average True Range (ATR)
- ABLV 0.03
- JSPR 0.12
- MACD
- ABLV 0.01
- JSPR 0.01
- Stochastic Oscillator
- ABLV 100.00
- JSPR 16.36
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.